173 related articles for article (PubMed ID: 23139120)
1. Roles of phosphoinositides and phosphoinositides kinases in hepatitis C virus RNA replication.
Lee C
Arch Pharm Res; 2012 Oct; 35(10):1701-11. PubMed ID: 23139120
[TBL] [Abstract][Full Text] [Related]
2. In vitro replication models for the hepatitis C virus.
Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
[TBL] [Abstract][Full Text] [Related]
3. A class II phosphoinositide 3-kinase plays an indispensable role in hepatitis C virus replication.
Maehama T; Fukasawa M; Date T; Wakita T; Hanada K
Biochem Biophys Res Commun; 2013 Oct; 440(1):150-6. PubMed ID: 24055031
[TBL] [Abstract][Full Text] [Related]
4. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
5. Discovery of selective small molecule type III phosphatidylinositol 4-kinase alpha (PI4KIIIα) inhibitors as anti hepatitis C (HCV) agents.
Leivers AL; Tallant M; Shotwell JB; Dickerson S; Leivers MR; McDonald OB; Gobel J; Creech KL; Strum SL; Mathis A; Rogers S; Moore CB; Botyanszki J
J Med Chem; 2014 Mar; 57(5):2091-106. PubMed ID: 23944386
[TBL] [Abstract][Full Text] [Related]
6. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.
Mori K; Abe K; Dansako H; Ariumi Y; Ikeda M; Kato N
Biochem Biophys Res Commun; 2008 Jun; 371(1):104-9. PubMed ID: 18406345
[TBL] [Abstract][Full Text] [Related]
7. Nir2 Is an Effector of VAPs Necessary for Efficient Hepatitis C Virus Replication and Phosphatidylinositol 4-Phosphate Enrichment at the Viral Replication Organelle.
Wang H; Tai AW
J Virol; 2019 Nov; 93(22):. PubMed ID: 31484747
[TBL] [Abstract][Full Text] [Related]
8. New insights into structure and replication of the hepatitis C virus and clinical implications.
Poenisch M; Bartenschlager R
Semin Liver Dis; 2010 Nov; 30(4):333-47. PubMed ID: 20960374
[TBL] [Abstract][Full Text] [Related]
9. Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening.
Trotard M; Lepère-Douard C; Régeard M; Piquet-Pellorce C; Lavillette D; Cosset FL; Gripon P; Le Seyec J
FASEB J; 2009 Nov; 23(11):3780-9. PubMed ID: 19608626
[TBL] [Abstract][Full Text] [Related]
10. Host factors involved in the replication of hepatitis C virus.
Moriishi K; Matsuura Y
Rev Med Virol; 2007; 17(5):343-54. PubMed ID: 17563922
[TBL] [Abstract][Full Text] [Related]
11. Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA.
Abe K; Ikeda M; Dansako H; Naka K; Kato N
Virus Res; 2007 Apr; 125(1):88-97. PubMed ID: 17239465
[TBL] [Abstract][Full Text] [Related]
12. Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking.
Wang H; Perry JW; Lauring AS; Neddermann P; De Francesco R; Tai AW
Gastroenterology; 2014 May; 146(5):1373-85.e1-11. PubMed ID: 24512803
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
Deterding K; Tegtmeyer B; Cornberg M; Hadem J; Potthoff A; Böker KH; Tillmann HL; Manns MP; Wedemeyer H
J Hepatol; 2006 Dec; 45(6):770-8. PubMed ID: 17034895
[TBL] [Abstract][Full Text] [Related]
14. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
15. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
[TBL] [Abstract][Full Text] [Related]
16. c-Fos regulates hepatitis C virus propagation.
Kang SM; Lim S; Won SJ; Shin YJ; Lim YS; Ahn BY; Hwang SB
FEBS Lett; 2011 Oct; 585(20):3236-44. PubMed ID: 21920361
[TBL] [Abstract][Full Text] [Related]
17. The hepatitis C virus life cycle as a target for new antiviral therapies.
Pawlotsky JM; Chevaliez S; McHutchison JG
Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis C virus--structure, replication and therapeutical opportunities and the phenomenon of resistance].
Kowala-Piaskowska A
Postepy Biochem; 2006; 52(4):399-407. PubMed ID: 17536509
[TBL] [Abstract][Full Text] [Related]
19. [Replication of hepatitis C virus genome].
Kato N
Uirusu; 2008 Dec; 58(2):191-8. PubMed ID: 19374197
[TBL] [Abstract][Full Text] [Related]
20. Redox modulation of the hepatitis C virus replication complex is calcium dependent.
Choi J; Forman HJ; Ou JH; Lai MM; Seronello S; Nandipati A
Free Radic Biol Med; 2006 Nov; 41(9):1488-98. PubMed ID: 17023276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]